TPB vs HGYN vs MO Stock Comparison

Turning Point Brands, Hong Yuan Holding and Altria Prices as of Oct 26, 2026 Peers: Industry group
MO Altria Group, Inc.
$73.61 +7.0% 1M +13.8% 1Y
Market cap
$122.36B
P/E
15.3x
Revenue (TTM)
$23.46B
Div. yield
0.06%
Tobacco Consumer Staples
9 wins

Head to Head

11 decided of 12

Altria leads on 9 of the 12 questions below (Altria 9, Turning Point Brands 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionTPBHGYNMOLeader
Larger companyMarket capitalisation $1.29B $2.99M $122.36B MO
Cheaper on earningsLower P/E, profitable companies only 29.0x -29.9x 15.3x MO
Cheaper on forward earningsLower price / next fiscal year consensus EPS 55.8x — 12.6x MO
Faster revenue growthRevenue growth, trailing twelve months +24.5% +6.1% -0.6% TPB
More profitableNet margin, trailing twelve months 8.8% -17.9% 34.0% MO
Better return on capitalReturn on invested capital 9.1% — 38.9% MO
Less leveragedLower net debt / EBITDA — — 2.0x –
Higher dividend yieldTrailing dividend yield 0.00% — 0.06% MO
Better 1-year returnPrice return, last 12 months -28.4% -20.0% +13.8% MO
Better 5-year returnAnnualised price return, 5 years +11.6%/yr -27.5%/yr +9.2%/yr TPB
Less volatileAnnualised volatility, 1 year 56.5% 349.7% 26.8% MO
Higher overall scoreMean of the five percentile scores vs peers 53/100 11/100 65/100 MO

Percentile Scorecard

TPBHGYNMO

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisTPBHGYNMO
Valuation 32 #26 of 38 3 #39 of 40 76 #10 of 38
Growth 50 #18 of 35 24 #29 of 38 27 #26 of 35
Profitability 89 #5 of 36 11 #32 of 36 100 #1 of 36
Financial Health 79 #9 of 39 5 #38 of 40 21 #31 of 39
Shareholder Returns 17 #11 of 13 – 100 #1 of 13
Overall 53 11 65
  • TPB ranked among 40 companies in Tobacco and Cannabis
  • HGYN ranked among 41 companies in Staples Retail
  • MO ranked among 40 companies in Tobacco and Cannabis

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodTPBHGYNMOSPY
1 month +5.3%0.0%+7.0% -0.8%
3 months -17.0%+33.3%+1.0% +3.5%
6 months -18.2%-60.0%+11.5% +7.0%
Year to date -39.8%0.0%+27.7% +12.2%
1 year -28.4%-20.0%+13.8% +13.0%
3 years +229.2%+100.0%+87.3% +86.3%
3 years, per year +48.8%+26.0%+23.3% +23.1%
5 years +72.8%-80.0%+55.0% +68.6%
5 years, per year +11.6%-27.5%+9.2% +11.0%
10 years +423.7%—+14.1% +258.0%
10 years, per year +18.0%—+1.3% +13.6%

Risk

MeasureTPBHGYNMOSPY
Volatility, 1Y 56.5%349.7%26.8% 12.7%
Downside volatility, 1Y 66.2%541.5%29.6% 12.7%
Beta vs S&P 500, 1Y 0.610.24-0.52 1.00
Return / volatility, 1Y -0.50-0.060.52 1.02
Max drawdown, 5Y -61.4%-95.7%-30.6% -25.4%
From 52-week high -54.3%-73.3%-3.2% -1.8%
52-week high $142.98$0.15$76.07 $779.14
52-week low $55.23$0.02$54.72 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleTPBHGYNMO
P/E now vs peer median 29.2xmedian 16.5x -29.9xmedian 22.0x 15.4xmedian 16.5x
P/S now vs peer median 2.6xmedian 0.9x 5.3xmedian 0.5x 5.2xmedian 0.9x
EV/EBITDA now vs peer median —median 12.3x -33.8xmedian 9.8x 12.9xmedian 12.3x
P/FCF now vs peer median 66.7xmedian 23.1x -78.9xmedian 17.8x 13.5xmedian 23.1x
P/B now vs peer median 2.9xmedian 1.0x -13.0xmedian 3.0x -46.1xmedian 1.0x
PEG now vs peer median 0.56median 0.56 1.29median 1.18 2.01median 0.56

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsTPBHGYNMO
Revenue $507.23M $559.73K $23.46B
Gross profit $300.08M $370.82K $14.77B
Operating income $75.01M -$91.58K $10.97B
Net income $59.64M -$99.38K $7.97B
Free cash flow $19.63M -$37.82K $9.11B
EPS (diluted) $2.21 $0.00 $4.77
Cash & equivalents $270.20M $13.37K $2.37B
Total debt $1.18B – $24.58B
Shares (diluted) 20.16M 74.64M 1.67B
Enterprise value $399.27M $3.02M $108.52B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricTPBHGYNMO
P/E 29.2x -29.9x 15.4x
P/FCF 66.7x -78.9x 13.5x
P/Operating cash flow 40.6x -78.9x 13.1x
P/S 2.6x 5.3x 5.2x
P/B 2.9x -13.0x -46.1x
P/Tangible book 3.4x -12.3x -8.5x
EV/EBITDA – -33.8x 12.9x
EV/EBIT 17.8x -32.5x 13.2x
EV/Revenue 2.6x 5.3x 6.2x
EV/FCF 67.9x -78.6x 15.9x
EV/Operating cash flow 41.4x -78.6x 15.4x
PEG (3Y EPS CAGR) 0.56 1.29 2.01

Growth

14 metrics
MetricTPBHGYNMO
Revenue growth (1Y) 24.5% 6.1% -0.6%
Revenue CAGR (3Y) 11.1% – -2.0%
Gross profit growth (1Y) 31.0% 26.9% 1.8%
Gross profit CAGR (3Y) 16.3% – 1.1%
Operating income growth (1Y) -15.0% -268.5% -0.7%
Operating income CAGR (3Y) 0.3% -19.6% -1.8%
Net income growth (1Y) 23.8% -2,581% -9.3%
Net income CAGR (3Y) 69.6% -22.9% 5.4%
EPS growth (1Y) -7.6% -362.0% -8.5%
EPS CAGR (3Y) 52.4% -23.2% 7.7%
Operating cash flow growth (1Y) -46.5% 24.4% 6.0%
Operating cash flow CAGR (3Y) -14.0% – 2.2%
Free cash flow growth (1Y) -62.4% 24.4% 4.4%
Free cash flow CAGR (3Y) -24.4% – 2.0%

Profitability

14 metrics
MetricTPBHGYNMO
Gross margin 59.2% 66.2% 63.0%
EBITDA margin – -15.7% 47.8%
Operating margin 14.8% -16.4% 46.8%
Pretax margin 13.6% -16.4% 44.2%
Net margin 8.8% -17.9% 34.0%
FCF margin 3.9% -6.8% 38.8%
Operating cash flow margin 6.4% -6.8% 40.1%
Return on equity 14.2% – –
Return on assets 7.3% -16.4% 23.5%
Return on invested capital 9.1% – 38.9%
Return on capital employed 10.3% – 41.9%
Asset turnover 0.6x 0.9x 0.7x
Cash conversion (OCF / net income) 0.5x 0.4x 1.2x
Stock comp / revenue 1.8% – –

Financial Health

11 metrics
MetricTPBHGYNMO
Debt / assets 34.4% – 73.6%
Debt / equity 0.6x – -9.2x
Net debt / EBITDA – – 2.0x
Debt / FCF 15.0x – 2.7x
Liabilities / assets 46.9% 136.2% 108.0%
Equity / assets 53.1% -36.2% -8.0%
Interest coverage 2.7x – –
Current ratio 5.7x 0.8x 0.5x
Quick ratio 3.5x 0.5x 0.4x
Cash ratio 3.1x 0.0x 0.3x
Altman Z-score 3.77 -214.31 5.23

Shareholder Returns

7 metrics
MetricTPBHGYNMO
Dividend yield 0.5% – 5.8%
Net buyback yield -12.2% – 0.6%
Shareholder yield -11.7% – 6.4%
Payout ratio (earnings) 10.2% – 88.6%
Payout ratio (FCF) 30.9% – 77.5%
Dividend growth (1Y) 15.9% – 2.7%
Dividend CAGR (3Y) 11.9% – 1.8%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusTPBHGYNMO
Forward P/E 55.8xFY2026 – 12.6xFY2026
EPS, next fiscal year $1.17FY2026 – $5.83FY2026
EPS growth, next FY -62.4%FY2026 – +7.6%FY2026
EPS growth, the year after +59.0% – +4.3%
Revenue, next fiscal year $597.82MFY2026 – $19.71BFY2026
Revenue growth, next FY +29.1%FY2026 – -2.1%FY2026
Revenue growth, the year after +4.7% – -0.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersTPBHGYNMO
Held by institutions 99.9% – 64.0%
Institutions holding 231 – 2,547
Change in shares held, QoQ +8.1% – +3.6%
Institutions buying 138 – 1,348
Institutions selling 66 – 821
Buyers to sellers 2.09 – 1.64

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

TPBHGYNMO
TPB 1.00 -0.03 0.22
HGYN -0.03 1.00 -0.05
MO 0.22 -0.05 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, TPB, HGYN and MO?

Altria (MO) is the largest by market capitalisation: Turning Point Brands (TPB) $1.29B, Hong Yuan Holding (HGYN) $2.99M, Altria (MO) $122.36B.

Which stock is cheaper, TPB, HGYN and MO?

Altria (MO) trades on the lowest price-to-earnings ratio (Turning Point Brands (TPB) 29.0x, Hong Yuan Holding (HGYN) -29.9x, Altria (MO) 15.3x). On next year's consensus earnings, Altria (MO) is cheapest (Turning Point Brands (TPB) 55.8x, Altria (MO) 12.6x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Turning Point Brands (TPB) grew revenue fastest over the trailing twelve months: Turning Point Brands (TPB) +24.5%, Hong Yuan Holding (HGYN) +6.1%, Altria (MO) -0.6%.

Which company is more profitable?

Altria (MO) has the highest net margin (Turning Point Brands (TPB) 8.8%, Hong Yuan Holding (HGYN) -17.9%, Altria (MO) 34.0%). On return on invested capital, Altria (MO) leads (Turning Point Brands (TPB) 9.1%, Altria (MO) 38.9%).

Which stock has performed better?

Over the past year Altria (MO) returned the most: Turning Point Brands (TPB) -28.4%, Hong Yuan Holding (HGYN) -20.0%, Altria (MO) +13.8%. Over five years, Turning Point Brands (TPB) compounded fastest (Turning Point Brands (TPB) +11.6%/yr, Hong Yuan Holding (HGYN) -27.5%/yr, Altria (MO) +9.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Altria (MO) has the highest dividend yield: Turning Point Brands (TPB) 0.00%, Altria (MO) 0.06%. Hong Yuan Holding (HGYN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Altria (MO) has been the steadiest (Turning Point Brands (TPB) 56.5%, Hong Yuan Holding (HGYN) 349.7%, Altria (MO) 26.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, TPB, HGYN and MO?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Altria (MO) leads on 9. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.